D-dimer Testing Market to Reach US$ 2,269.31 Million by 2032 Supported by Growing Thromboembolic Disease Burden and Expansion of Point-of-Care Diagnostics Says Astute Analytica

The market expansion is primarily fueled by the increasing incidence of venous thromboembolism (VTE), deep vein thrombosis (DVT), pulmonary embolism (PE), and other blood-clotting disorders worldwide.
TCTMD

Patient Age Adds Key Context to D-Dimer in DVT Diagnosis: ADJUST-DVT

Age-adjusted D-dimer cutoffs can safely rule out deep vein thrombosis (DVT) in many suspected cases, according to the ADJUST-DVT trial. For patients ages 50 and older with a nonhigh or unlikely ...
MedPage Today

DVT Assessment Strategy Safely Expands Rule-Out

A prospective validation study found that age-adjusted D-dimer thresholds can safely rule out lower extremity DVT for more people with low to intermediate suspicion in the first place. The ...